← FDA Drug Approvals (Drugs@FDA)

OLAPARIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS USA INC · Approved 2025-11-06

Drug application

FDA Application #
ANDA219893
Application type
Abbreviated New Drug Application (Generic)
Brand name
OLAPARIB
Generic name
Olaparib
Active ingredients
OLAPARIB
Dosage form
TABLET
Route
—
Marketing status
None (Tentative Approval)
Sponsor
ZYDUS PHARMS USA INC
First approval
2025-11-06

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown